Front Line Genomics is delighted to announce the launch of D4 Global: the world’s first truly global event focusing on […]
Damage to the DNA in cells is the root cause of cancer, but it is also a weakness of the […]
A study conducted by a team at UCL identified potential drug and vaccine targets for SARS-CoV-2. The results of the […]
Jo Balfour, one of the founding members and current Operations Manager at Cambridge Rare Disease Network (CRDN), has collaborated with […]
Cancer Research UK (CRUK), the University of Southampton and the London-based biotechnology company Touchlight Genetics have announced a new partnership […]
A team of researchers from Italy have identified multiple genetic variants that could play a role in determining the severity […]
As we move towards an ever more personalised healthcare system, genomics is at the heart of what makes an individual […]
Alastair Greystoke joined Newcastle University and the Northern Centre for Cancer Care, in Newcastle upon Tyne, UK, in 2014 after […]
Genomics has the potential to improve efficacy of drugs and accelerate precision healthcare, but one area with the biggest potential […]
Through a massively parallel in-vivo process called the GigaAssay, Heligenics produces what is called a Gene Mutation/Function Library (“GMLs”). Each […]
